A randomized phase III trial of Gemzar [gemcitabine] versus Doxil [doxorubicin liposomal] with crossover treatment option for patients with platinum-resistant ovarian, fallopian tube or primary peritoneal cancer undergoing second or third-line chemotherapy
Phase of Trial: Phase III
Latest Information Update: 28 Oct 2005
At a glance
- Drugs Doxorubicin liposomal; Gemcitabine
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Registrational; Therapeutic Use
- 28 Oct 2005 New trial record.